We're another step closer to getting another vaccine on the market.
Moderna announced Wednesday that the first trial volunteers have received boosters of their COVID-19 vaccine, some of them modified to target a variant.
December has been the nation's deadliest month since the COVID-19 pandemic's start, with more than 63,000 Americans lost to the virus in the past 26 days.